Preventive therapy for complicated diverticular disease of the colon: Looking for a correct therapeutic approach [4]

Gastroenterology

Volumn 127, Issue 6, 2004, Pages 1865-1866

  Tursi, Antonio ^a  

^a Lorenzo Bonomo Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 4; MESALAZINE; PROBIOTIC AGENT; PROSTAGLANDIN SYNTHASE; RIFAXIMIN; SALICYLIC ACID; THROMBOXANE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANTIOXIDANT ACTIVITY; BIFIDOBACTERIUM; COLON DIVERTICULOSIS; COLON PERFORATION; COLON STENOSIS; CYTOKINE RELEASE; DRUG SAFETY; HUMAN; HYPOTENSION; INTESTINE FLORA; LACTOBACILLUS; LETTER; NEPHROTOXICITY; PERIPHERAL EDEMA; PRIORITY JOURNAL; RECURRENT DISEASE;

EID: 9644273918     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.10.030     Document Type: Letter

References (14)

1. K. Mitchell, N.J. Shaheen Preventive therapy in perforated colonic diverticular disease? Calcium channel blockers may hold the key Gastroenterology 127 2004 680 682
2. C.R. Morris, I.M. Harvey, W.S.L. Stebbings, C.T.M. Speakman, H.J. Kennedy, A.R. Hart Do calcium channel blockers and antimuscarinics protect against perforated colonic diverticular disease? Gut 52 2003 1734 1737
3. M.J. Eisenberg, A. Brox, A.N. Bastawros Calcium channel blockers an update Am J Med 116 2004 35 43
4. R. Eliakim, D. Rachmilewitz Potential mediators in inflammatory bowel disease Gastroenterology Int 5 1992 48 56
5. M.B. Grisham Oxidants and free radicals in inflammatory bowel disease Lancet 344 1994 859 861
6. E. Gonçalves, L.M. Almeida, T.C. Dinis Antioxidant activity of 5-aminosalicylic acid against peroxidation of phosphatidylcholine liposomes in the presence of alpha-tocopherol a synergistic interaction? Free Rad Res 29 1998 53 66
7. G. Rogler, T. Andus Cytokins in inflammatory bowel disease World J Surg 22 1998 382 389
8. A.A. Izzo, N. Mascolo, F. Capasso Nitric oxide as a modulator of intestinal water and electrolyte transport Dig Dis Sci 43 1998 1605 1620
9. A. Tursi, G. Brandimarte, R. Daffinà Long-term treatment with mesalazine and rifaximin versus rifaximin alone for the patients with recurrent attacks of acute diverticulitis of the colon Dig Liver Dis 34 2002 510 515
10. G. Brandimarte, A. Tursi Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease Med Sci Monit 10 2004 170 173
11. W.J. Sandborn, S.B. Hanauer Systematic review the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis Aliment Pharmacol Ther 17 2003 29 42
12. F. Shanahan Inflammatory bowel disease immunodiagnostics, immunotherapeutics, and echotherapeutics Gastroenterology 120 2001 622 635
13. N. Borruel, F. Casellas, M. Antolin, M. Llopis, M. Carol, E. Espiin, J. Naval, F. Guarner, J.R. Malagelada Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa Am J Gastroenterol 98 2003 865 870
14. P. Frič, M. Zavoral The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon Eur J Gastroenterol Hepatol 15 2003 313 315